Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
用于研究全身真菌感染的油下开放式微流体系统 (UOMS)
基本信息
- 批准号:10552700
- 负责人:
- 金额:$ 77.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-02-01 至 2026-01-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibioticsBacterial InfectionsBiological AssayBlood CirculationCandidaCandida albicansCandidiasisCathetersCell CountCellsClinicalCollecting CellCritical IllnessDevicesDiseaseDrug TargetingDrug resistanceEffectivenessEnvironmentFoundationsGenerationsGeneticGenetic DeterminismGrowthHealth Care CostsHealthcareHeterogeneityHuman bodyImmunocompromised HostIn VitroIncidenceIndividualInfectionInterventionLibrariesLifeLiquid substanceMeasurementMeasuresMethodsMicrobial BiofilmsMicrofluidic MicrochipsMicrofluidicsMorbidity - disease rateMycosesNeoplasm MetastasisOilsPatientsPharmaceutical PreparationsPhenotypePhysiologicalPreventionProcessPropertySepsisSiteSolidSurfaceSystemTechnologyTherapeuticVirulenceVirulence FactorsWettabilityWorkYeastsattributable mortalitycandida biofilmcandidemiafungusin vitro Assayin vivoinnovationinstrumentationmortalitymutantnoveloperationpathogenic fungusscreeningtool
项目摘要
Project Summary/Abstract
Opportunistic fungal pathogens are a leading cause of healthcare associated bloodstream infections. Candida
yeasts, specifically, cause 80-90% of biofilm-associated invasive fungal infections and mortality rates can
approach 50%. Furthermore, the incidence of Candida infections is rising with the increased use of catheter and
other device-based interventions. To date, the majority of work related to fungal infections and potential
treatments has focused on biofilms and their prevention. However, recent evidence suggests that the dispersion
of yeast cells from the biofilm (into the bloodstream) and the persistence of these dispersed cells are
perhaps more important virulence factors and represent significant but underutilized treatment targets.
Further, existing assays and instrumentation are not amenable to measuring dispersion and phenotyping
dispersed cells. Nor do they recapitulate in vivo conditions (e.g. flow, interaction with host cells). Thus, here we
will develop a new type of under-oil open microfluidic system (UOMS) to quantify the dispersive capacity of
biofilms and assess the phenotype of dispersed cells in Candida mutants and clinical isolates. The UOMS
platform is built on the foundation of a newly observed phenomena called Exclusive Liquid Repellency (ELR).
ELR provides a unique environment where liquid is completely repelled from a solid surface to eliminate
biofouling. Additionally, ELR expands the capabilities of simple open microfluidic devices allowing us to
overcome the limitations of current methods and provide a system capable of quantitatively studying fungal
dispersion. We will first (Aim 1) develop an under-oil microchannel device to measure the dispersive capacity of
Candida biofilms and virulence phenotypes. Second (Aim 2) we will automate the UOMS and develop a single-
cell distribution assay to measure the phenotype of individual dispersed cells. And finally (Aim 3), we will use the
UOMS platform to develop dispersion phenotype profiles for Candida mutant libraries and clinical isolates. We
will measure the dispersive capacity and phenotype of dispersed cells from hundreds of Candida albicans clinical
isolates and mutants available in existing libraries, providing clues to the genetic determinants of dispersion.
项目概要/摘要
机会性真菌病原体是医疗保健相关血液感染的主要原因。念珠菌属
具体来说,酵母菌会导致 80-90% 的生物膜相关侵袭性真菌感染,并且死亡率可
接近50%。此外,随着导管和导管使用的增加,念珠菌感染的发生率也在上升。
其他基于设备的干预措施。迄今为止,大部分工作与真菌感染和潜在的
治疗的重点是生物膜及其预防。然而,最近的证据表明,分散
酵母细胞从生物膜(进入血液)的数量以及这些分散细胞的持久性
也许是更重要的毒力因素,代表着重要但未充分利用的治疗目标。
此外,现有的测定和仪器不适合测量分散性和表型分析
分散的细胞。它们也没有概括体内条件(例如流动、与宿主细胞的相互作用)。因此,在这里我们
将开发一种新型油下开放式微流体系统(UOMS)来量化
生物膜并评估念珠菌突变体和临床分离株中分散细胞的表型。伦敦大学管理学院
平台建立在一种新观察到的现象的基础上,称为排斥液体(ELR)。
ELR 提供了一个独特的环境,液体与固体表面完全排斥,以消除
生物污垢。此外,ELR 扩展了简单开放式微流体设备的功能,使我们能够
克服现有方法的局限性,提供一种能够定量研究真菌的系统
分散。我们将首先(目标 1)开发油下微通道装置来测量油下微通道的分散能力
念珠菌生物膜和毒力表型。第二(目标 2)我们将使 UOMS 自动化并开发一个单一的
细胞分布测定来测量单个分散细胞的表型。最后(目标 3),我们将使用
UOMS 平台用于开发念珠菌突变体文库和临床分离株的分散表型谱。我们
将测量数百个临床白色念珠菌的分散细胞的分散能力和表型
现有文库中提供的分离株和突变体,为分散的遗传决定因素提供了线索。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David J Beebe其他文献
David J Beebe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David J Beebe', 18)}}的其他基金
Development of a human intestinal microphysiological system for the study of immune responses to protozoan parasites
开发人体肠道微生理系统用于研究原生动物寄生虫的免疫反应
- 批准号:
10733303 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
用于研究全身真菌感染的油下开放式微流体系统 (UOMS)
- 批准号:
10209529 - 财政年份:2021
- 资助金额:
$ 77.08万 - 项目类别:
Under-oil open microfluidic system (UOMS) for studying systemic fungal infection
用于研究全身真菌感染的油下开放式微流体系统 (UOMS)
- 批准号:
10333399 - 财政年份:2021
- 资助金额:
$ 77.08万 - 项目类别:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
利用多相微流体增强稀有细胞的表观遗传分析
- 批准号:
10552039 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
微环境介导的癌细胞表面靶向治疗耐药机制
- 批准号:
10686449 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
A multiplexed micro scale assay for real time analysis of pediatric immune cell function
用于实时分析儿科免疫细胞功能的多重微量测定
- 批准号:
10132990 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
微环境介导的癌细胞表面靶向治疗耐药机制
- 批准号:
10707411 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
利用多相微流体增强稀有细胞的表观遗传分析
- 批准号:
10094211 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics
微环境介导的癌细胞表面靶向治疗耐药机制
- 批准号:
10263962 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
Enhancing Epigenetic Analysis Of Rare Cells With Multi-Phase Microfluidics
利用多相微流体增强稀有细胞的表观遗传分析
- 批准号:
10331769 - 财政年份:2020
- 资助金额:
$ 77.08万 - 项目类别:
相似国自然基金
基于抗生素-AIE探针的细菌胞外囊泡检测新方法的构建及其在血流感染中的应用价值研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
以活性为导向的硫肽类抗生素的衍生及其在口腔细菌感染性疾病中的应用研究
- 批准号:81974495
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
基于免疫调节发掘有毒动物来源天然多肽抗耐药胞内细菌感染
- 批准号:81872839
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
细菌响应抗生素释放系统的建立及对骨感染病灶的靶向治疗作用研究
- 批准号:81802178
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
基于Teixobactin的新型抗耐药菌及抗耐药结核病药物研究
- 批准号:81773567
- 批准年份:2017
- 资助金额:55.0 万元
- 项目类别:面上项目
相似海外基金
An Integrated Catheter Dressing for Early Detection of Catheter-related Bloodstream Infections
用于早期检测导管相关血流感染的集成导管敷料
- 批准号:
10647072 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms
开发一类针对碳青霉烯类耐药革兰氏阴性生物的新型肽抗生素
- 批准号:
10674131 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Using strain history to improve prediction of the evolution of antimicrobial resistance in Acinetobacter baumannii
利用菌株历史改进对鲍曼不动杆菌抗菌药物耐药性演变的预测
- 批准号:
10677362 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Development of Targeted Antipseudomonal Bactericidal Prodrugs
靶向抗假单胞菌杀菌前药的开发
- 批准号:
10678074 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别:
Project 2: Ex Vivo Modeling and Analysis of Gastric Precancerous Lesions
项目2:胃癌前病变的离体建模与分析
- 批准号:
10715763 - 财政年份:2023
- 资助金额:
$ 77.08万 - 项目类别: